Neil Goldsmith joined Basel Area Business & Innovation in 2018.
Previously, Neil Goldsmith was CEO and board member of Evolva SA, which he co-founded in 2004, taking it from a startup biotech venture to a leading synthetic biology company listed on the Swiss stock exchange. He co-founded Topotarget A/S and Personal Chemistry AB, now Biotage AB. He further founded and managed various life science ventures at an early stage.
Neil Goldsmith holds a 1st class honors degree in Zoology from Balliol College, Oxford University and set up his first company in 1984. He is a board member of Unibio and Double Bioventures.